Association of Umbilical Cord Blood P-Selectin and PTX3 Levels with Early-Onset Sepsis in Preterm Infants with Premature Rupture of Membranes Authors: Yong Luo, Mingyue Li, Wei Liu, Wenlong Xiu Published: 2026 ABSTRACT AbstractObjectiveTo investigate the relationship between umbilical cord blood P-selectin and pentraxin 3 (PTX3) levels and early-onset sepsis (EOS) in preterm neonates with premature rupture of membranes (PROM).MethodsA total of 148 preterm neonates with PROM duration >12 h admitted from September 2024 to September 2025 were included as the experimental group, including 22 with EOS and 126 without EOS. Fifty healthy preterm neonates born to mothers without PROM were enrolled as controls. Umbilical cord blood P-selectin and PTX3 levels were measured by ELISA. Pathogens were identified using an automated bacterial identification system. Pearson correlation analysis and ROC curve analysis were performed.ResultsUmbilical cord blood P-selectin and PTX3 levels were higher in the experimental group than in controls (P<0.05). Among the 22 neonates with EOS, 6 (27.3%) had positive blood cultures, yielding 6 pathogenic strains. Gram-negative bacteria predominated (66.67%), mainly Escherichia coli (33.33%). Compared with the non-sepsis group, the sepsis group had higher CRP, PCT, P-selectin, and PTX3 levels (P<0.05). P-selectin was positively correlated with PTX3 in neonates with EOS (r=0.639, P<0.05). The AUCs (95% CI) of P-selectin and PTX3 for evaluating EOS were 0.876 (0.814–0.937) and 0.883 (0.830–0.935), respectively. Their combined AUC was 0.911 (0.862–0.960), with sensitivity of 79.2% and specificity of 96.1%, outperforming CRP and PCT.ConclusionGram-negative bacteria were the main pathogens of EOS in preterm neonates with PROM. Umbilical cord blood P-selectin and PTX3 levels showed good value for evaluating EOS in this population.Keywords: premature rupture of membranes, preterm infants, early-onset sepsis, umbilical cord blood, P-selectin, pentraxin 3, prediction Introduction When the gestational age is less than 37 weeks, spontaneous rupture of the fetal membranes is called preterm premature rupture of membranes (PPROM), which is relatively common during the perinatal period.1 Clinical studies worldwide have shown that the incidence of PPROM has increased significantly in recent years and has become one of the high-risk factors leading to neonatal infection.2,3 Bacterial infection in premature infants can cause early-onset sepsis, which increases neonatal mortality and seriously threatens their lives and health.4 Therefore, it is particularly important to identify early indicators associated with early-onset sepsis in preterm infants with PPROM. P-selectin, an important substance in the platelet activation process, helps platelets aggregate at sites of vascular injury and plays a crucial role in pathological processes such as infection and trauma.5 Pentraxin 3 (PTX3) is an acute-phase reaction protein and an inflammatory mediator complex receptor produced by various innate and inflammatory cells.6 Davoudian et al7 reported that prognostic indicators such as PTX3 may serve as predictors of sepsis mortality. Although both P-selectin and PTX3 are associated with infectious diseases, research on their roles in early-onset sepsis of preterm infants remains limited. This study aimed to investigate the predictive value of umbilical cord blood P-selectin and PTX3 levels for early-onset sepsis in preterm neonates with premature rupture of membranes. Umbilical cord blood samples were prospectively collected from preterm neonates with premature rupture of membranes, and P-selectin and PTX3 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). The correlations of these biomarkers with the occurrence and severity of early-onset sepsis were analyzed, and the predictive performance of each marker alone and in combination was evaluated. This study sought to clarify the potential roles of P-selectin and PTX3 in the early pathological process of early-onset sepsis and to provide clues for understanding the underlying immune-inflammatory mechanisms. The findings are expected to be translated into an early warning tool for assessing the risk of early-onset sepsis based on umbilical cord blood testing immediately after birth, thereby enabling timely identification and intervention in high-risk neonates. This has clear clinical significance for improving the prognosis of preterm neonates and reducing neonatal mortality. Materials and Methods General Data Planned sample size: According to the results of the preliminary experiment, α = 0.01, β = 0.05, 1 − β = 0.95, and the effect size d = 0.65 (Calculated based on the C-reactive protein (CRP) levels in the experimental and control groups from the preliminary experimental results). The required sample size was calculated using PASS 15.0, showing that at least 46 samples were needed, which met the study requirements. All participants or their families were informed of the purpose, significance, and methods of this study and voluntarily signed informed consent. The study was approved by the hospital’s ethics committee. All procedures strictly followed the principles of Good Clinical Practice. Experimental group inclusion criteria: ① A total of 148 preterm infants (< 37 weeks’ gestation) delivered vaginally between September 2024 and September 2025 with rupture of membranes lasting > 12 hours were selected as the study group (experimental group) (To ensure relative consistency in labor exposure and stress status among the enrolled neonates, and to more specifically analyze the relationship between premature rupture of membranes and biomarker levels, neonates delivered by cesarean section were excluded from this study). ② All mothers had singleton pregnancies. ③ Complete clinical data were available. Control group inclusion criteria: ① Fifty preterm infants without rupture of membranes, born to healthy mothers during the same period, and matched for sex, gestational age, and birth weight, were selected as the control group. ② The newborns showed no clinical signs of infection after birth. Exclusion criteria: ① Combined hepatic or renal dysfunction, or congenital heart disease. ② Mycoplasma or fungal infection. ③ Congenital metabolic disorders. The case collection flowchart is shown in Figure 1. Case Collection Flowchart. Diagnostic criteria for rupture of membranes:8 ① Clinical manifestations: A sudden gush of fluid from the vagina, possibly mixed with vernix caseosa or meconium. ② Vaginal speculum examination: Amniotic fluid accumulation in the posterior fornix or leakage from the cervical os. ③ Vaginal pH test: pH > 6.5. ④ Vaginal smear examination: Vaginal fluid placed on a slide and dried shows fern-like crystallization under microscopy; or 0.5% Nile blue sulfate staining shows orange fetal epithelial cells; or Sudan III staining shows yellow fat granules. ⑤ Amnioscope examination: Direct visualization of the presenting part without the presence of an intact forebag. Diagnostic criteria for neonatal early-onset sepsis:9 Onset within 72 hours after birth, meeting any of the following conditions: (1) Confirmed diagnosis: Clinical symptoms plus any of the following: a. Pathogenic bacteria isolated from blood culture or sterile body cavity; b. If a conditional pathogen is isolated from a blood culture specimen, the same bacteria must also be isolated from another blood specimen, sterile body cavity, or catheter tip culture. (2) Clinical diagnosis: Clinical symptoms plus any of the following: a. Two or more nonspecific test results are abnormal; b. Detection of bacterial antigen or DNA in blood specimens is positive. Main Reagents and Instruments P-selectin ELISA kit (catalog No. ZN2355) was purchased from Wuhan Saibei Biotechnology Co., Ltd.; PTX3 ELISA kit (catalog No. ZN2725) from Wuhan Saibei Biotechnology Co., Ltd. Fully automatic microplate reader (model FC) was purchased from Thermo Fisher Scientific (USA); microbial monitoring system (model BacT/Alert 3D) from bioMérieux (France); automatic bacterial identification instrument (model Phoenix 100) from BD (USA). Research Methods General Data Collection The general information of all participating mothers and newborns was collected, including maternal age, maternal body mass index (BMI), gravidity, primiparity ratio, neonatal sex, gestational age at birth, birth weight, C-reactive protein (CRP), procalcitonin (PCT), white blood cell (WBC) count, and maternal fever. Sample Collection and Preservation Umbilical cord blood (5 mL) was collected from each newborn after cord clamping, centrifuged (3000 r/min, 10 min), and the supernatant serum was stored at −80 °C for the detection of P-selectin and PTX3 levels. Pathogen Culture and Identification After birth, at least 1 mL of whole blood was aseptically collected from each newborn and inoculated into pediatric aerobic and anaerobic blood culture bottles, respectively. The blood culture bottles were placed in an automated blood culture system and continuously monitored at 35±1°C for 5 days. When a culture bottle signaled positive, smear Gram staining and microscopic examination were performed immediately, followed by subculture onto blood agar plates, chocolate agar plates, and other media for isolation culture. After culture, pathogen identification was performed using an automatic bacterial identification instrument. According to the pathogen identification results and the diagnostic criteria for neonatal early-onset sepsis,9 148 preterm infants with PPROM were divided into a sepsis group (22 cases) and a non-sepsis group (126 cases). Determination of Umbilical Cord Blood P-Selectin and PTX3 Levels P-selectin and PTX3 levels in umbilical cord blood were measured using the ELISA method according to the manufacturer’s instructions. Before use, all reagents and umbilical cord blood samples were equilibrated at room temperature for 30 min. The samples were tested directly without dilution, and the standards were serially diluted to generate the standard curve. Blank wells and duplicate standard wells were included on each plate. The absorbance was read at 450 nm using an automated microplate reader, and the concentrations were calculated according to the linear regression equation of the standard curve. Quality control: To ensure the accuracy of the assay, strict quality control procedures were applied. The correlation coefficients (R2) of the standard curves were all >0.99. Precision was evaluated by testing low-, medium-, and high-concentration quality control samples. The intra-assay coefficient of variation (CV) was <10%, and the inter-assay CV was <15%, meeting the requirements for quantitative detection. Statistical Analysis Statistical analysis was performed using SPSS 25.0. Data with a normal distribution were expressed as mean ± SD (), and the t test was used for comparison. Categorical data were expressed as frequency (n) or percentage (%), and the chi-square test was used. Pearson correlation analysis was applied to assess the relationship between P-selectin and PTX3 levels in preterm infants with membrane rupture > 12 hours. ROC curve analysis was used to evaluate the predictive value of indicators. A P value < 0.05 was considered statistically significant. Results Comparison of Basic Maternal and Neonatal Data and Umbilical Cord Blood P-Selectin and PTX3 Levels Between the Control and Experimental Groups There were no statistically significant differences (P > 0.05) in neonatal sex, gestational age, birth weight, maternal age, or parity between the control and experimental groups. However, umbilical cord blood P-selectin and PTX3 levels were significantly higher in the experimental group compared with the control group (P < 0.05). See Table 1. Table 1Comparison of General Information, the Levels of P-Selectin and PTX3 of Experimental Group and Control Group of Pregnant Women and Newborns[()/N]GroupNumberMaternal Age (Years)First Delivery (Yes/No)Newborn Gender (Male/Female)Newborns Born at Gestational Age (Week)Newborn Birth Weight (kg)P-Selectin (μg/L)PTX3 (μg/L)Experimental group14829.03±5.4487/6172/7634.21±1.372.19±0.2724.42±6.987.88±1.86Control group5029.29±5.8730/2028/2234.39±1.452.20±0.3910.22±3.263.24±0.97t/χ2–0.2870.0230.8080.7920.20113.86916.867P–0.7750.8800.3690.4290.8410.0000.000 Comparison of General Information, the Levels of P-Selectin and PTX3 of Experimental Group and Control Group of Pregnant Women and Newborns[()/N] Comparison of Maternal and Neonatal General Data Between the Sepsis and Non-Sepsis Groups Within the experimental group, there were no statistically significant differences (P > 0.05) between the sepsis and non-sepsis groups in terms of maternal age, maternal BMI, or gravidity. The sepsis group showed significantly higher CRP and PCT levels than the non-sepsis group (P < 0.05). See Table 2. Table 2Comparison of General Information of Two Groups of Pregnant Women and Newborns[()/N]GroupNumberMaternal Age (Years)Maternal BMI (kg/m2)Pregnancy Times (Times)First Delivery (Yes/No)Newborn Gender (Male/Female)Newborns Born at Gestational Age (Week)Newborn Birth Weight (kg)Non sepsis group12628.94±5.3724.72±1.411.28±0.3571/5563/6334.14±1.762.19±0.23Sepsis group2229.12±5.5224.57±1.361.30±0.3016/69/1334.28±1.692.17±0.31t/χ2–0.1440.4630.2522.0740.6200.3460.356P–0.8850.6440.8010.1500.4310.7300.722GroupNumberCRP (mg/L)PCT (ng/mL)WBC (×109/L)Maternal Fever (Yes/No)Non sepsis group1264.12±1.450.38±0.1310.45±3.6211/115Sepsis group227.04±2.491.36±0.2711.68±4.753/19t/χ2–7.70226.8481.4000.109P–0.0000.0000.1640.741 Comparison of General Information of Two Groups of Pregnant Women and Newborns[()/N] Distribution of Pathogenic Bacteria in Neonates of the Sepsis Group Among the 22 neonates clinically diagnosed with early-onset sepsis, 6 cases (27.3%) had positive blood culture results, while the remaining 16 cases were confirmed by clinical diagnosis. A total of 6 pathogenic strains were isolated. Gram-positive bacteria accounted for 33.33%, mainly Staphylococcus aureus and Enterococcus faecalis, each representing 16.67%. Gram-negative bacteria accounted for 66.67%, primarily Escherichia coli, which represented 33.33%. See Table 3. Table 3Distribution of Pathogenic Bacteria in Neonates in the Sepsis GroupGroupBacteriumNumber of Bacterial StrainsDistribution Rate (%)Gram-positive bacteriaStaphylococcus aureus116.67Staphylococcus epidermidis00.00Enterococcus faecalis116.67Gram-negative bacteriaEscherichia coli233.33Pseudomonas aeruginosa116.67Klebsiella pneumoniae00.00Enterobacter cloacae116.67Total6100.00 Distribution of Pathogenic Bacteria in Neonates in the Sepsis Group Comparison of Umbilical Cord Blood P-Selectin and PTX3 Levels Between the Two Groups Umbilical cord blood P-selectin and PTX3 levels in the sepsis group were significantly higher than those in the non-sepsis group (P < 0.05). See Table 4. Table 4Comparison of P-Selectin and PTX3 Levels in Umbilical Cord Blood Between Two Groups (, μg/L)GroupNumberP-SelectinPTX3Non sepsis group12618.69±5.146.47±1.64Sepsis group2230.46±8.929.38±2.10t–8.7287.349P–0.0000.000 Comparison of P-Selectin and PTX3 Levels in Umbilical Cord Blood Between Two Groups (, μg/L) Correlation Between Umbilical Cord Blood P-Selectin and PTX3 Levels in Preterm Infants with Rupture of Membranes >12 Hours Pearson correlation analysis showed a positive correlation between umbilical cord blood P-selectin and PTX3 levels in preterm infants with preterm premature rupture of membranes lasting more than 12 hours (r = 0.639, P < 0.05) (Figure 2). Correlation between P-selectin and PTX3 levels in umbilical cord blood of newborns in the sepsis group. Combined Evaluation Value of Umbilical Cord Blood P-Selectin and PTX3 Levels for Early-Onset Sepsis in Preterm Infants with Premature Rupture of Membranes, and Comparison with the Efficacy of CRP and PCT A binary logistic regression model was established to evaluate early-onset sepsis in preterm infants with PPROM using each indicator: Logit(P) = −7.456 + 1.002 × P-selectin + 0.936 × PTX3. Using umbilical cord blood P-selectin and PTX3 levels as test variables, ROC curves were drawn. The results showed that the combined evaluation of P-selectin and PTX3 for early-onset sepsis in preterm infants with PPROM had an area under the curve (AUC) of 0.911(0.862–0.960) and a specificity of 96.1%, both superior to their individual assessments. See Table 5 and Figure 3A. Table 5The Evaluation Value of Combined Levels of P-Selectin and PTX3 in Cord Blood for Early-Onset Sepsis in Preterm Infants with Premature Rupture of MembranesIndicatorsAUC (95% CI)Truncation ValueSensitivity (%)Specificity (%)Youden IndexP-selectin0.876(0.814–0.937)24.339 μg/L79.2%92.1%0.713PTX30.883(0.830–0.935)7.584 μg/L80.6%81.6%0.622Cooperation0.911(0.862–0.960)–79.2%96.1%0.753 The Evaluation Value of Combined Levels of P-Selectin and PTX3 in Cord Blood for Early-Onset Sepsis in Preterm Infants with Premature Rupture of Membranes Comparison of P-selectin, PTX3, CRP, and PCT in diagnosing early-onset sepsis in preterm infants with PROM.(A) ROC curve of umbilical cord blood P-selectin and PTX3 for early-onset sepsis.(B) ROC curve of CRP and PCT for early-onset sepsis. The AUCs of the conventional laboratory indicators CRP and PCT for evaluating early-onset sepsis in preterm infants with PPROM were 0.843(0.777–0.909) and 0.821(0.762–0.960), respectively, both lower than the combined AUC of P-selectin and PTX3 (P<0.05). See Table 6 and Figure 3B. Table 6Evaluation Value of Routine Laboratory Indicators for Early-Onset Sepsis in Premature Infants with Premature Premature Rupture of MembranesIndicatorsAUC (95% CI)Truncation ValueSensitivity (%)Specificity (%)Youden IndexCRP0.843(0.777–0.909)5.62 mg/L78.6%79.2%0.578PCT0.821(0.762–0.960)0.78 ng/mL70.6%90.9%0.615 Evaluation Value of Routine Laboratory Indicators for Early-Onset Sepsis in Premature Infants with Premature Premature Rupture of Membranes Discussion The mechanism of preterm premature rupture of membranes (PPROM) remains uncertain. Differences in maternal constitution and individual conditions can lead to variations in the latency period of PPROM.10 After membrane rupture, amniotic fluid outflow and changes in the intrauterine environment significantly increase the likelihood of early-onset sepsis.11 Currently, clinical diagnosis of neonatal infection following PPROM relies mainly on pathogen culture, which is time-consuming. Moreover, when membrane rupture lasts for more than 12 hours, prophylactic antibiotic administration to the mother may result in false-negative culture outcomes.12,13 In this study, a follow-up of 148 preterm infants with PPROM revealed that 22 of them developed early-onset sepsis—a relatively high infection rate. This may be attributed to the immaturity of organ function in preterm infants, making them more susceptible to infection than term infants. Among the six bacterial strains identified in the 22 cases of early-onset sepsis, Escherichia coli accounted for the highest proportion (33.33%). Serapio-Palacios et al14 reported that E. coli is one of the leading causes of infant diarrhea and mortality worldwide. Similarly, Guo et al15 found that among pregnant women with bloodstream infections, E. coli was the predominant pathogen, accounting for 48%. The findings of this study are consistent with these reports. PTX3 is mainly produced by tissue and immune cells at inflammatory sites, induced by tumor necrosis factor-α and interleukin-1β.16,17 Compared with common inflammatory markers, PTX3 is closely associated not only with septic shock, organ damage, and cardiovascular diseases but also reflects local tissue injury and inflammation in a timely manner.18 The results of this study showed that PTX3 levels in umbilical cord blood were significantly higher in preterm infants with early-onset sepsis secondary to PPROM than in those without sepsis. This suggests that PTX3 in umbilical cord blood may serve as an important indicator for evaluating bacterial infection and early-onset sepsis in neonates. P-selectin, a member of the adhesion molecule family, is typically stored in endothelial cell granules and resting platelet α-granules. When endothelial cells are stimulated, P-selectin rapidly translocates to the cell surface.19,20 Studies have shown that P-selectin mediates endothelial adhesion and leukocyte chemotaxis during inflammation.21 The present results demonstrated that P-selectin levels in umbilical cord blood were significantly higher in preterm infants with early-onset sepsis after PPROM than in those without sepsis, and that P-selectin was an influencing factor of early-onset sepsis. Elevated umbilical cord blood P-selectin levels may therefore indicate bacterial infection and early-onset sepsis in PPROM neonates. Scavello et al22 reported that PTX3 can effectively assist clinicians in diagnosing secondary fungal or bacterial infections, which partially aligns with the present findings. Correlation analysis in this study revealed a positive correlation between P-selectin and PTX3 levels in preterm infants with early-onset sepsis secondary to PPROM, both indicating bacterial infection and inflammatory injury. ROC curve analysis further showed that the combined predictive AUC of P-selectin and PTX3 was 0.911, with a specificity of 96.1%, outperforming either marker alone. Compared with conventional laboratory indicators such as CRP and PCT, the combined evaluation also showed superior predictive performance. This suggests that both markers can be used as auxiliary predictors of early-onset sepsis in preterm infants, potentially improving survival rates and clinical outcomes.In addition, the findings of this study have clear value for guiding clinical practice. Based on the cut-off values identified in this study (P-selectin >24.339 μg/L and PTX3 >7.584 μg/L), an early risk stratification and management pathway for early-onset sepsis in preterm neonates with premature rupture of membranes may be preliminarily established. In clinical practice, for preterm neonates with premature rupture of membranes lasting >12 h, umbilical cord blood can be collected immediately at birth to measure P-selectin and PTX3 levels. Specifically, if both biomarkers are below the cut-off values, the risk of early-onset sepsis is relatively low, and a more conservative antibiotic strategy may be considered under close clinical observation, which may help reduce unnecessary antibiotic exposure and related risks, such as intestinal dysbiosis and the emergence of drug-resistant bacteria. Conversely, if either marker or the combined markers are markedly above the cut-off values, especially when the combined assessment indicates a high risk [AUC=0.911 (0.862–0.960)], clinicians should be highly alert to early-onset sepsis. In such cases, empirical anti-infective therapy may be initiated or intensified earlier and more actively, and these neonates should receive more intensive monitoring while awaiting conventional test results such as blood culture. In summary, Gram-negative bacteria are the main pathogens causing early-onset sepsis in preterm infants with PPROM, with Escherichia coli being the most common. Umbilical cord blood P-selectin and PTX3 levels demonstrate high specificity and sensitivity in predicting early-onset sepsis in preterm infants and may serve as valuable biological markers for clinical assessment. Further investigation into the predictive value of P-selectin and PTX3 for neonatal early-onset sepsis could play a crucial role in reducing subsequent treatment burdens for families and improving neonatal health outcomes. However, this study has certain limitations. First, this was a single-center study and the number of sepsis cases was relatively small; therefore, the small sample size may introduce bias, increase the risk of overfitting, and limit the generalizability of the findings due to the absence of external validation, necessitating further verification with larger cohorts. Second, due to limited samples, subgroup analyses based on gestational age or types of bacterial infection were not conducted. Third, as the number of influencing factors included was relatively small,and confounding factors such as maternal antibiotic exposure were not adjusted for in this study,future studies should incorporate additional risk factors along with P-selectin and PTX3 to construct a comprehensive predictive model for early-onset sepsis. Fourth, among the 22 neonates with early-onset sepsis, 6 cases were confirmed by blood culture, whereas the remaining 16 cases were clinically diagnosed. Combining these two types of cases may introduce outcome heterogeneity and thereby lead to classification bias. Fifth, heterogeneity exists in the diagnosis of early-onset sepsis. Funding Statement This work was supported by the Scientific Research Project of the Education Department of Hunan Province (No. 21C0596), the Hunan Provincial Natural Science Foundation of China (No. 2023JJ60056) and the Fujian Provincial Natural Science Foundation of China (No. 2022J02049). Data Sharing Statement The original contributions presented in the study are included in the article. Ethics Approval This study involving human participants was conducted in accordance with the ethical standards of the Medical Ethics Committee of The First Affiliated Hospital of Shaoyang University (K2022-001-01) and with the 1964 Helsinki Declaration. Written informed consent was obtained from all patients (or their legal guardians), who all signed the informed consent form prior to their inclusion in the study. Consent for Publication All authors give consent for publication. Disclosure The authors have no conflicts of interest to disclose for this work. References Associated Data Data Availability Statement The original contributions presented in the study are included in the article.